Literature DB >> 21652164

Thoracic sympathectomy for digital ischemia: a summary of evidence.

Hans M E Coveliers1, Frank Hoexum, Johanna H Nederhoed, Willem Wisselink, Jan A Rauwerda.   

Abstract

BACKGROUND: Thoracic sympathectomy is used in the management of a variety of upper limb disorders. We have analyzed the evidence for thoracic sympathectomy in the management of digital ischemia.
METHODS: We reviewed the English literature between 1980 and 2010. Our analysis included reports with the clinical end points of relief, recurrence of symptoms or healing of ulcers, or both. Primary Raynaud disease (PRD) and secondary Raynaud phenomenon (SRP) were analyzed separately.
RESULTS: An initial postoperative positive effect was reported in 92% of PRD patients and in 89% of SRP patients. Long-term beneficial effect was 58% for PRD and 89% for SRP. Ulcer healing or improvement was achieved in 95%.
CONCLUSIONS: The available evidence suggests that thoracic sympathectomy has a role in the treatment of severe PRD and SRP, albeit with better results in SRP patients than in PRD patients. In case of digital ulceration, thoracic sympathectomy may maximize tissue preservation or prevent amputation.
Copyright © 2011 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21652164     DOI: 10.1016/j.jvs.2011.01.069

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  11 in total

1.  Thoracoscopic anatomy and approaches of the anterior thoracic spine: cadaver study.

Authors:  Bashar Abuzayed; Yakup Tuna; Nurperi Gazioglu
Journal:  Surg Radiol Anat       Date:  2012-02-29       Impact factor: 1.246

Review 2.  Thoracic sympathectomy: a review of current indications.

Authors:  Moshe Hashmonai; Alan E P Cameron; Peter B Licht; Chris Hensman; Christoph H Schick
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

3.  Extended Periarterial Sympathectomy: Evaluation of Long-term Outcomes.

Authors:  Collier S Pace; Wyndell H Merritt
Journal:  Hand (N Y)       Date:  2017-06-23

4.  In Reply.

Authors:  Peter Klein-Weigel
Journal:  Dtsch Arztebl Int       Date:  2021-09-06       Impact factor: 5.594

5.  Botulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review.

Authors:  Paweł Żebryk; Mariusz J Puszczewicz
Journal:  Arch Med Sci       Date:  2015-01-08       Impact factor: 3.318

Review 6.  Raynaud's Phenomenon: A Brief Review of the Underlying Mechanisms.

Authors:  Manal M Fardoun; Joseph Nassif; Khodr Issa; Elias Baydoun; Ali H Eid
Journal:  Front Pharmacol       Date:  2016-11-16       Impact factor: 5.810

7.  Near-infrared Intraoperative Imaging of Thoracic Sympathetic Nerves: From Preclinical Study to Clinical Trial.

Authors:  Kunshan He; Jian Zhou; Fan Yang; Chongwei Chi; Hao Li; Yamin Mao; Bengang Hui; Kun Wang; Jie Tian; Jun Wang
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

8.  Recovery of sympathetic nerve function after lumbar sympathectomy is slower in the hind limbs than in the torso.

Authors:  Zhi-Fang Zheng; Yi-Shu Liu; Xuan Min; Jian-Bing Tang; Hong-Wei Liu; Biao Cheng
Journal:  Neural Regen Res       Date:  2017-07       Impact factor: 5.135

9.  Bilateral uniportal video-assisted thoracoscopic sympathectomy for managing secondary Raynaud's in CREST syndrome: A case report.

Authors:  Yasser Aljehani; Atteia Alhouri; Alaa Turkistani; Rahma ShahBahai; Abdullah A AlQatari
Journal:  Int J Surg Case Rep       Date:  2020-08-31

10.  Treatment of resistant Raynaud's phenomenon with single-port thoracoscopic sympathicotomy: a novel minimally invasive endoscopic technique.

Authors:  Anniek M van Roon; Michiel Kuijpers; Saskia C van de Zande; Amaal Eman Abdulle; Arie M van Roon; Reinhard Bos; Wobbe Bouma; Theo J Klinkenberg; Hendrika Bootsma; Mike J L DeJongste; Massimo A Mariani; Andries J Smit; Douwe J Mulder
Journal:  Rheumatology (Oxford)       Date:  2020-05-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.